申请人:Schering Aktiengesellschaft
公开号:US05616573A1
公开(公告)日:1997-04-01
Glucocorticoids of general formula I R--Val--O--GC (II), are described, in which O-GC is the radical of a 21-hydroxycorticoid that has an antiinflammatory action, Val represents a valine radical in the 21-position of the corticoid and R means a hydrogen atom or a hydrocarbon radical with up to 32 carbon atoms that is optionally substituted by hydroxy groups, amino groups, oxo groups and/or halogen atoms and/or interrupted by oxygen atoms, SO.sub.2 groups and/or NH groups and their salts.
描述了一般式I R--Val--O--GC(II)的糖皮质激素,其中O-GC是具有抗炎作用的21-羟基皮质激素的基团,Val代表皮质激素21位的缬氨酸基团,R表示氢原子或最多具有32个碳原子的碳氢基团,该基团可选地被羟基、氨基、氧代基和/或卤素原子取代和/或由氧原子、SO.sub.2基团和/或NH基团中断,并且它们的盐。